Reprimo as a modulator of cell migration and invasion in the MDA-MB-231 breast cancer cell line

BACKGROUND: Reprimo (RPRM), a highly glycosylated protein, is a new downstream effector of p53-induced cell cycle arrest at the G2/M checkpoint, and a putative tumor suppressor gene frequently silenced via methylation of its promoter region in several malignances. The aim of this study was to charac...

Full description

Bibliographic Details
Main Authors: Kurt Buchegger, Carmen Ili, Ismael Riquelme, Pablo Letelier, Alejandro H. Corvalán, Priscilla Brebi, Tim Hui-Ming Huang, Juan Carlos Roa
Format: Article
Language:English
Published: BMC
Series:Biological Research
Subjects:
Online Access:http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0716-97602016000100005&lng=en&tlng=en
_version_ 1811198464391905280
author Kurt Buchegger
Carmen Ili
Ismael Riquelme
Pablo Letelier
Alejandro H. Corvalán
Priscilla Brebi
Tim Hui-Ming Huang
Juan Carlos Roa
author_facet Kurt Buchegger
Carmen Ili
Ismael Riquelme
Pablo Letelier
Alejandro H. Corvalán
Priscilla Brebi
Tim Hui-Ming Huang
Juan Carlos Roa
author_sort Kurt Buchegger
collection DOAJ
description BACKGROUND: Reprimo (RPRM), a highly glycosylated protein, is a new downstream effector of p53-induced cell cycle arrest at the G2/M checkpoint, and a putative tumor suppressor gene frequently silenced via methylation of its promoter region in several malignances. The aim of this study was to characterize the epigenetic inactivation and its biological function in BC cell lines. METHODS: The correlation between RPRM methylation and loss of mRNA expression was assessed in six breast cancer cell lines by methylation specific PCR (MSP), 5'-Aza-2'-deoxycytidine treatment and RT-PCR assays. MDA-MB-231 cells were chosen to investigate the phenotypic effect of RPRM in cell proliferation, cell cycle, cell death, cell migration and invasion. RESULTS: In the cancer methylome system (CMS) (web-based system for visualizing and analyzing genome-wide methylation data of human cancers), the CpG island region of RPRM (1.1 kb) was hypermethylated in breast cancer compared to normal breast tissue; more interesting still was that ERa(+) tumors showed higher methylation intensity than ERa(-). Downregulation of RPRM mRNA by methylation was confirmed in MDA-MB-231 and BT-20 cell lines. In addition, overexpression of RPRM in MDA-MB-231 cells resulted in decreased rates of cell migration, wound healing and invasion in vitro. However, RPRM overexpression did not alter cell viability, phosphatidylserine (PS) translocation or G2/M cell cycle transition. CONCLUSION: Taken together, these data suggest that RPRM is involved in decreased cell migration and invasion in vitro, acting as a potential tumor suppressor gene in the MDA-MB-231 cell line.
first_indexed 2024-04-12T01:32:13Z
format Article
id doaj.art-bac59d27ff9243939a55891e1b8d58fa
institution Directory Open Access Journal
issn 0716-9760
language English
last_indexed 2024-04-12T01:32:13Z
publisher BMC
record_format Article
series Biological Research
spelling doaj.art-bac59d27ff9243939a55891e1b8d58fa2022-12-22T03:53:27ZengBMCBiological Research0716-976049011010.1186/s40659-016-0066-7S0716-97602016000100005Reprimo as a modulator of cell migration and invasion in the MDA-MB-231 breast cancer cell lineKurt Buchegger0Carmen Ili1Ismael Riquelme2Pablo Letelier3Alejandro H. Corvalán4Priscilla Brebi5Tim Hui-Ming Huang6Juan Carlos Roa7Universidad de La FronteraUniversidad de La FronteraUniversidad de La FronteraUniversidad Católica de TemucoPontificia Universidad Catolica de ChileUniversidad de La FronteraUniversity of Texas Health Science CenterPontificia Universidad Católica de ChileBACKGROUND: Reprimo (RPRM), a highly glycosylated protein, is a new downstream effector of p53-induced cell cycle arrest at the G2/M checkpoint, and a putative tumor suppressor gene frequently silenced via methylation of its promoter region in several malignances. The aim of this study was to characterize the epigenetic inactivation and its biological function in BC cell lines. METHODS: The correlation between RPRM methylation and loss of mRNA expression was assessed in six breast cancer cell lines by methylation specific PCR (MSP), 5'-Aza-2'-deoxycytidine treatment and RT-PCR assays. MDA-MB-231 cells were chosen to investigate the phenotypic effect of RPRM in cell proliferation, cell cycle, cell death, cell migration and invasion. RESULTS: In the cancer methylome system (CMS) (web-based system for visualizing and analyzing genome-wide methylation data of human cancers), the CpG island region of RPRM (1.1 kb) was hypermethylated in breast cancer compared to normal breast tissue; more interesting still was that ERa(+) tumors showed higher methylation intensity than ERa(-). Downregulation of RPRM mRNA by methylation was confirmed in MDA-MB-231 and BT-20 cell lines. In addition, overexpression of RPRM in MDA-MB-231 cells resulted in decreased rates of cell migration, wound healing and invasion in vitro. However, RPRM overexpression did not alter cell viability, phosphatidylserine (PS) translocation or G2/M cell cycle transition. CONCLUSION: Taken together, these data suggest that RPRM is involved in decreased cell migration and invasion in vitro, acting as a potential tumor suppressor gene in the MDA-MB-231 cell line.http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0716-97602016000100005&lng=en&tlng=enReprimoMDA-MB-231MigrationInvasion
spellingShingle Kurt Buchegger
Carmen Ili
Ismael Riquelme
Pablo Letelier
Alejandro H. Corvalán
Priscilla Brebi
Tim Hui-Ming Huang
Juan Carlos Roa
Reprimo as a modulator of cell migration and invasion in the MDA-MB-231 breast cancer cell line
Biological Research
Reprimo
MDA-MB-231
Migration
Invasion
title Reprimo as a modulator of cell migration and invasion in the MDA-MB-231 breast cancer cell line
title_full Reprimo as a modulator of cell migration and invasion in the MDA-MB-231 breast cancer cell line
title_fullStr Reprimo as a modulator of cell migration and invasion in the MDA-MB-231 breast cancer cell line
title_full_unstemmed Reprimo as a modulator of cell migration and invasion in the MDA-MB-231 breast cancer cell line
title_short Reprimo as a modulator of cell migration and invasion in the MDA-MB-231 breast cancer cell line
title_sort reprimo as a modulator of cell migration and invasion in the mda mb 231 breast cancer cell line
topic Reprimo
MDA-MB-231
Migration
Invasion
url http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0716-97602016000100005&lng=en&tlng=en
work_keys_str_mv AT kurtbuchegger reprimoasamodulatorofcellmigrationandinvasioninthemdamb231breastcancercellline
AT carmenili reprimoasamodulatorofcellmigrationandinvasioninthemdamb231breastcancercellline
AT ismaelriquelme reprimoasamodulatorofcellmigrationandinvasioninthemdamb231breastcancercellline
AT pabloletelier reprimoasamodulatorofcellmigrationandinvasioninthemdamb231breastcancercellline
AT alejandrohcorvalan reprimoasamodulatorofcellmigrationandinvasioninthemdamb231breastcancercellline
AT priscillabrebi reprimoasamodulatorofcellmigrationandinvasioninthemdamb231breastcancercellline
AT timhuiminghuang reprimoasamodulatorofcellmigrationandinvasioninthemdamb231breastcancercellline
AT juancarlosroa reprimoasamodulatorofcellmigrationandinvasioninthemdamb231breastcancercellline